Abliva AB (OMX:ABLI)

European company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ABLI

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ABLI

  • Market CapSEK0.000m
  • SymbolOMX:ABLI
  • IndustryHealthcare
  • Sector-
  • Currency
  • ISINSE0002575340

Company Profile

Abliva AB is a Swedish company which is active in pharmaceutical development. Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.NeuroVive Pharmaceutical AB focuses on the discovery and development of targeted drug candidates that preserve mitochondrial integrity and function in areas of unmet medical need.

Latest ABLI news

Currently there for this company. Visit our news hub for other news .